DepoDur

Generic Name:
morphine sulfate extended-release liposome injection
Date of Approval: May 18, 2004
Company: SkyePharma PLC and Endo Pharmaceuticals
Treatment for: Post-Surgical Pain Relief

The United States Food and Drug Administration (FDA) has approved DepoDur (previously referred to as DepoMorphine) for the treatment of pain following major surgery.
DepoDur is a novel single dose sustained-release injectable formulation of morphine providing 48 hours of post-surgical pain relief.

For more information, please visit
http://www.drugs.com/depodur.html